1/23
02:34 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
1/12
01:14 pm
nbix
Rating for NBIX
Low
Report
Rating for NBIX
1/8
08:02 am
nbix
Neurocrine Biosciences (NASDAQ:NBIX) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $175.00 price target on the stock, up previously from $173.00.
Low
Report
Neurocrine Biosciences (NASDAQ:NBIX) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $175.00 price target on the stock, up previously from $173.00.
1/8
08:02 am
nbix
Neurocrine Biosciences (NASDAQ:NBIX) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $175.00 price target on the stock, up previously from $173.00.
Low
Report
Neurocrine Biosciences (NASDAQ:NBIX) had its "equal weight" rating reaffirmed by analysts at Morgan Stanley. They now have a $175.00 price target on the stock, up previously from $173.00.
1/8
07:15 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
1/8
07:15 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
1/8
06:22 am
nbix
Neurocrine downgraded to Equal Weight from Overweight at Morgan Stanley
Low
Report
Neurocrine downgraded to Equal Weight from Overweight at Morgan Stanley
1/8
06:22 am
nbix
Neurocrine downgraded to Equal Weight from Overweight at Morgan Stanley
Low
Report
Neurocrine downgraded to Equal Weight from Overweight at Morgan Stanley
12/12
09:16 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
12/12
09:16 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
12/11
08:28 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
12/8
09:35 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
12/8
09:35 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
11/11
07:41 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX
11/11
07:41 am
nbix
Rating for NBIX
Low
Report
Rating for NBIX